Sanofi shaves 207 R&D jobs in scaled-back reorg

Under assault from union leaders and government officials, Sanofi ($SNY) was forced to back off plans to engineer a major reorganization of its R&D operations in France. But it's going ahead with a scaled-back effort aimed at concentrating its forces in key corporate hubs while trimming the overall number of researchers on the payroll. Report